Evidence map›Paper›PMID 18500344›Full record

ArticleNature immunology2008

The chromatin-remodeling enzyme BRG1 coordinates CIITA induction through many interdependent distal enhancers.

Zuyao Ni, Mohamed Abou El Hassan, Zhaodong Xu, Tao Yu, Rod Bremner

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Transcriptional control of interferon-stimulated genes.The Journal of biological chemistry · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Chromatin-Remodeling Factor BRG1 Is a Negative Modulator ofFrontiers in cellular and infection microbiology · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Macrophage-specific MHCII expression is regulated by a remoteThe Journal of experimental medicine · 2018
    Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Zuyao NiGenetics and Development Division, Toronto Western Research Institute, University Health Network, Toronto, Ontario M5T 2S8, Canada.
Mohamed Abou El Hassan
Zhaodong Xu
Tao Yu
Rod Bremner
University of Toronto · CAUniversity Health Network · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The chromatin-remodeling enzyme BRG1 is critical for interferon-gamma (IFN-gamma)-mediated gene induction. Promoter-proximal elements are sufficient to mediate BRG1 dependency at some IFN-gamma targets. In contrast, we show here that at CIITA, which encodes the 'master regulator' of induction of major histocompatibility complex class II, distal elements conferred BRG1 dependency. At the uninduced locus, many sites formed BRG1-independent loops. One loop juxtaposed a far downstream element adjacent to a far upstream site. Notably, BRG1 was recruited to the latter site, which triggered the appearance of a histone 'mark' linked to activation. This subtle change was crucial, as subsequent IFN-gamma-induced recruitment of the transcription factors STAT1, IRF1 and p300, as well as histone modifications, accessibility and additional loops, showed BRG1 dependency. Like BRG1, each remote element was critical for the induction of CIITA expression. Thus, BRG1 regulates CIITA through many interdependent remote enhancers, not through the promoter alone.

Indexed as

Gene Expression RegulationChromatinDNA HelicasesEnhancer Elements, GeneticGene ExpressionGenes, RegulatorHeLa CellsHumansInterferon-gammaNuclear ProteinsOligonucleotide Array Sequence AnalysisPolymerase Chain ReactionPromoter Regions, GeneticTrans-ActivatorsTranscriptional ActivationTranscription FactorsChromatinDNA HelicasesInterferon-gammaMHC class II transactivator proteinNuclear ProteinsSMARCA4 protein, humanTrans-ActivatorsTranscription Factors

Identifiers

PMID18500344
OpenAlexW2115889959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.